RecruitingNot ApplicableNCT05885022
Feasibility Clinical Evaluation of the Calibreye System
Sponsor
Myra Vision Inc.
Enrollment
60 participants
Start Date
May 31, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing a new device called the Calibreye System for treating glaucoma — a condition where fluid builds up in the eye and damages the optic nerve. The device is designed to drain excess fluid and lower eye pressure.
**You may be eligible if...**
- You have open-angle glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma
- Your eye pressure is between 18 and 45 mmHg before the procedure
- Your vision has been measurably affected by glaucoma
- The tissue around your eye in the target area is healthy and mobile
**You may NOT be eligible if...**
- You have angle-closure glaucoma or certain other types of secondary glaucoma
- You have had most types of prior eye surgery (other than uncomplicated cataract surgery more than 3 months ago)
- You have had a previous glaucoma drainage device in the target area
- You have an active eye infection or inflammation
- You have had corneal surgery or have corneal scarring
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECalibreye System
Implantation of a glaucoma device to reduce intraocular pressure
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05885022
Related Trials
A Trial of Hydrus Microstent Versus Goniotomy
NCT062894911 location
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
NCT060666451 location
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT056259586 locations
Electrical Stimulation for the Treatment of Optic Neuropathies
NCT056264261 location
Optic Nerve Head Strain as Biomarker for Glaucoma
NCT062403121 location